Voyager Therapeutics Inc (NASDAQ: VYGR) flaunted slowness of -0.25% at $3.93, as the Stock market unbolted on Wednesday, before settling in for the price of $3.94 at the close. Taking a more long-term approach, VYGR posted a 52-week range of $2.64-$6.27.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 1.48%. Meanwhile, its Annual Earning per share during the time was 1.48%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -85.01%. This publicly-traded company’s shares outstanding now amounts to $55.48 million, simultaneously with a float of $45.82 million. The organization now has a market capitalization sitting at $218.50 million. At the time of writing, stock’s 50-day Moving Average stood at $4.26, while the 200-day Moving Average is $3.76.
Voyager Therapeutics Inc (VYGR) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Voyager Therapeutics Inc industry. Voyager Therapeutics Inc’s current insider ownership accounts for 17.59%, in contrast to 54.70% institutional ownership. According to the most recent insider trade that took place on Oct 03 ’25, this organization’s Chief Financial Officer sold 7,666 shares at the rate of 4.78, making the entire transaction reach 36,643 in total value, affecting insider ownership by 123,834.
Voyager Therapeutics Inc (VYGR) Earnings and Revenue Records
Voyager Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -85.01% and is forecasted to reach -1.60 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -9.77% through the next 5 years, which can be compared against the 1.48% growth it accomplished over the previous five years trading on the market.
Voyager Therapeutics Inc (NASDAQ: VYGR) Trading Performance Indicators
Let’s observe the current performance indicators for Voyager Therapeutics Inc (VYGR). It’s Quick Ratio in the last reported quarter now stands at 6.19. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 6.98.
In the same vein, VYGR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.17, a figure that is expected to reach -0.51 in the next quarter, and analysts are predicting that it will be -1.60 at the market close of one year from today.
Technical Analysis of Voyager Therapeutics Inc (VYGR)
Now, what If we examine the latest scores posted by [Voyager Therapeutics Inc, VYGR]. During the last 5-days, its volume was lower the volume of 0.56 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 12.78% While, its Average True Range was 37.24.
Raw Stochastic average of Voyager Therapeutics Inc (VYGR) in the period of the previous 100 days is set at 36.72%, which indicates a major rise in contrast to 10.96% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.20 that was lower than 0.26 volatility it exhibited in the past 100-days period.
